Daily Respiratory Research Analysis
Analyzed 183 papers and selected 3 impactful papers.
Summary
Analyzed 183 papers and selected 3 impactful articles.
Selected Articles
1. IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.
Using human nasopharyngeal tonsil tissues, the authors show that secreted IgD responses are primarily generated by IgD class-switched, atypical-like memory B cells residing across mucosal niches. These IgD memory cells arise via a mutation-intensive program and display reactivity to respiratory commensals, environmental antigens, and allergens, shaping mucosal homeostasis and tolerance.
Impact: This work defines the cellular origin and targets of mucosal IgD responses, reframing how upper-airway humoral immunity engages commensals and allergens. It provides a mechanistic foundation for designing mucosal vaccines and tolerance-inducing strategies.
Clinical Implications: Insights into IgD memory B-cell biology could inform next-generation intranasal vaccines that balance protection and tolerance, and suggest biomarkers or targets for allergic airway disease by modulating IgD-mediated recognition.
Key Findings
- IgD+IgM- plasma cells clonally derive from IgD class-switched, atypical-like memory B cells in nasopharyngeal mucosa.
- These IgD memory B cells arise via a mutation-intensive program integrating innate and adaptive signals.
- IgD responses target respiratory commensals, environmental antigens, and allergens; reactivity diminishes in germline IgD revertants.
Methodological Strengths
- Comprehensive tissue-resident B-cell profiling with clonal lineage analysis and transcriptional phenotyping across mucosal niches
- Functional reactivity assessment to commensals and environmental antigens linking phenotype to function
Limitations
- Human ex vivo tissue analyses without in vivo interventional validation limit causal inference.
- Sample size and donor heterogeneity are not fully detailed, potentially affecting generalizability.
Future Directions: Test whether modulating IgD memory B-cell pathways alters mucosal tolerance versus inflammation in vivo, and leverage these circuits for intranasal vaccine or allergy desensitization strategies.
Human tonsils from the nasopharyngeal mucosa mount frontline antibody responses, including IgD secretion by IgD+IgM- plasma cells (IgD-PCs). The developmental origins and functional significance of these IgD responses remain poorly understood. Here, we show that most IgD-PCs clonally emerge from a heterogeneous population of IgD class-switched IgD+IgM- memory (IgD-ME) B cells that reside within the epithelial, subepithelial, and interfollicular areas of the nasopharyngeal mucosa and share transcriptional and phenotypic properties with atypical B cells. These IgD-ME B cells arise from a mutation-intensive pathway that involves integrated innate and adaptive signals and engenders reactivities to respiratory commensal bacteria, common environmental antigens, and allergens. Such reactivities weaken in germline IgD revertants. Thus, the secreted IgD response heavily relies on nasopharyngeal mucosal IgD-ME B cells via a germinal center-imprinted mutational program that presumably enhances mucosal homeostasis and environmental tolerance.
2. PKR condensation at viral replication complexes initiates its activation.
PKR initiates activation by condensing on dsRNA exposed at membrane-bound viral replication complexes, then dissolves to release active PKR that phosphorylates eIF2α and triggers the ISR. Viral accessory proteins (e.g., MERS-CoV NS4a) can competitively occupy dsRNA to block PKR condensation and activation.
Impact: This study reframes antiviral sensing by revealing a condensation-based activation mechanism for PKR at replication complexes, and identifies a viral strategy that blocks this step. It opens avenues for antiviral interventions targeting condensation dynamics or viral dsRNA-binding proteins.
Clinical Implications: Therapeutics that enhance PKR condensation or prevent viral proteins from sequestering dsRNA could potentiate innate antiviral responses against coronaviruses and related RNA viruses.
Key Findings
- PKR activates via condensation on dsRNA at membrane-associated replication complexes of MERS-CoV and ZIKV.
- Activated p-PKR dissociates, enabling cytosolic ISR signaling and monomer exchange to amplify activation.
- MERS-CoV NS4a blocks PKR activation by competitively condensing on viral dsRNA.
Methodological Strengths
- Multi-modal imaging (super-resolution confocal, immunogold TEM, live-cell) and proximity ligation assays across viruses
- Mechanistic dissection of condensate dynamics linked to downstream ISR signaling
Limitations
- Predominantly cell-based mechanistic studies without in vivo therapeutic validation.
- Work focuses on selected positive-strand RNA viruses; generalizability to others remains to be shown.
Future Directions: Define small molecules that modulate PKR condensates and test efficacy against coronaviruses; map the condensation interactome to identify host or viral co-factors as drug targets.
Protein kinase R (PKR) is a critical component of mammalian intracellular antiviral immunity. Here, we examine the process of PKR activation in response to Middle East respiratory syndrome coronavirus (MERS-CoV) and Zika virus (ZIKV) using super-resolution confocal microscopy, proximity ligation assay, immunogold transmission electron microscopy, and live-cell imaging. Our data support that PKR activates upon condensation on double-stranded RNA (dsRNA) exposed at membrane-associated viral replication complexes. Subsequently, p-PKR condensates disassociate from dsRNA and dissolve, releasing activated PKR molecules into the cytosol, where they phosphorylate eIF2α to initiate the integrated stress response (ISR). Importantly, the disassociation of p-PKR from dsRNA allows for the exchange of inactive PKR monomers, thus promoting robust PKR activation from limited exposed viral dsRNA substrates. MERS-CoV NS4a prevents PKR activation via competitive condensation on viral dsRNA. These findings establish a comprehensive model for PKR activation in response to positive-strand RNA viruses that replicate within membrane-associated complexes.
3. Distinct fibrosis-associated macrophage subsets coordinate iron metabolism in pulmonary fibrosis.
BALF scRNA-seq and histology identified SPP1/APOE macrophages in ILD, enriched in fibrotic foci and increased in IPF/PPF. Two iron-regulatory subsets (SLC40A1+ and HAMP+) are tuned by IL-10/IL-8 from epithelial sources, enabling iron flux and accumulation that trigger SPP1+ myofibroblast transition and a ferroptosis–TGF-β1 loop.
Impact: Revealing iron-metabolism–driven macrophage-fibroblast circuits provides actionable targets (e.g., hepcidin–ferroportin axis, IL-8/IL-10 modulation) and biomarkers for pulmonary fibrosis progression.
Clinical Implications: Therapeutic modulation of SLC40A1/HAMP pathways or epithelial IL-8/IL-10 signals may attenuate fibrotic remodeling; iron-handling markers could stratify progression risk in IPF/PPF.
Key Findings
- SPP1/APOE macrophages accumulate within fibrotic foci and are increased in IPF and progressive pulmonary fibrosis.
- Two subsets—SLC40A1+ and HAMP+ macrophages—are regulated by IL-10 and IL-8 from alveolar type II cells and bronchial epithelium, respectively.
- Iron provision (SLC40A1) and intracellular iron accumulation (HAMP) drive SPP1+ myofibroblast transition; ferroptotic fibroblasts secrete TGF-β1, reinforcing fibrosis.
Methodological Strengths
- Patient-derived BALF single-cell RNA-seq integrated with spatial histology to localize macrophage subsets
- Cytokine–receptor axis mapping linking epithelial cues to macrophage iron programs and fibroblast state transitions
Limitations
- Observational human omics with limited interventional or longitudinal validation; causality requires in vivo perturbation.
- Quantitative sample sizes and external validation cohorts are not detailed in the abstract.
Future Directions: Evaluate hepcidin–ferroportin and IL-8/IL-10 pathway inhibitors in preclinical lung fibrosis models; develop iron-metabolism–based biomarkers for patient stratification and therapy response.
Pulmonary fibrosis has a poor prognosis due to challenges in early diagnosis and therapeutic intervention. Current treatments remain largely ineffective due to an incomplete understanding of the complex pathology, including the interactions between fibroblasts and profibrotic immune cells within fibrotic lungs. To elucidate the dynamics of fibrosis, we performed single-cell RNA sequencing (scRNA-seq) on bronchoalveolar lavage fluid (BALF) obtained from patients with interstitial lung disease (ILD). We identified the SPP1- and APOE-expressing macrophage population that is commonly present across ILDs. Histological analysis showed that this macrophage population accumulated at the center of fibrotic foci. Furthermore, the ratio of this macrophage population was increased in both progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF). Transcriptomic analysis further divided this macrophage population into two subsets: SLC40A1+ or HAMP+ fibrosis-associated macrophages. We found that the relative balance of IL-10 and IL-8 regulated SLC40A1 and HAMP expression within fibrosis-associated macrophages. Additionally, histological analysis revealed that bronchial epithelium expressed IL-8, while type II alveolar epithelial cells expressed IL-10 in the fibrotic lung. SLC40A1+ fibrosis-associated macrophages localized to CD31+ perivascular regions and mediated the uptake and degradation of the hemoglobin-haptoglobin complex. This dual pathway-providing iron via SLC40A1 and intracellular iron accumulation via HAMP-facilitated the transition of fibroblasts into SPP1+ myofibroblasts. Moreover, ferroptotic fibroblasts secreted TGF-β1, which further contributes to fibrotic progression. In conclusion, aberrant iron metabolism orchestrated by fibrosis-associated macrophages may contribute to fibrosis by facilitating the transition of myofibroblasts. These findings provide mechanistic insight into the progression of autonomous pulmonary fibrosis.